Natco Pharma Limited Lenalidomide Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Lenalidomide Export Records India — #7 Exporter, 31 Shipments, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Natco Pharma Limited — Lenalidomide Exporter #7 | $1.1M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Lenalidomide Exporter Profile

Indian Pharmaceutical Exporter · #7 for Lenalidomide · $1.1M export value · DGFT Verified

Natco Pharma Limited is the #7 Indian exporter of Lenalidomide with $1.1M in export value and 31 verified shipments. Natco Pharma Limited holds a 0.1% market share in Lenalidomide exports across 6 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Lenalidomide Export Profile: Buyers & Destinations

Natco Pharma Limited Lenalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Lenalidomide?

Country	Value	Shipments	Share
UNITED STATES	$234.9K	5	45.9%
CANADA	$105.7K	3	20.7%
SAUDI ARABIA	$100.0K	2	19.5%
PHILIPPINES	$43.3K	3	8.5%
NEPAL

Who Are the Top Buyers of Lenalidomide from Natco Pharma Limited?

Buyer	Country	Value	Orders
TEVA PHARMACEUTICALS USA INC	UNITED STATES	$150.0K	3
NATCO PHARMA (CANADA) INC	CANADA	$105.7K	3
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$100.0K	2
TEVA PHARMACEUTICALS USA INC,	UNITED STATES	$84.9K	2
NATCO LIFESCIENCES PHILIPPINES INC,	PHILIPPINES	$43.3K	3
EVEREST BANK LTD	NEPAL	$12.5K	4
EVEREST BANK LTD.	NEPAL	$9.8K	2
EVEREST BANK LIMITED	NEPAL	$5.2K	2
NATCOFARMA DO BRASIL LTDA	BRAZIL	$30	4
NATCOFARMA DO BRASIL LIMITEDA	BRAZIL	$0	6

Natco Pharma Limited supplies Lenalidomide to 10 buyers globally. The largest buyer is TEVA PHARMACEUTICALS USA INC (UNITED STATES), followed by NATCO PHARMA (CANADA) INC (CANADA) and BOSTON ONCOLOGY ARABIA (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lenalidomide Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
LENALIDOMIDE CAPSULES 20 MG 21'S (4991X21'S)(APPENDIX 4RRODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CINO:123260)NOS	$150.0K	3
NAT-LENALIDOMIDE 5MG CAPSULES 28'S (OTHE	$50.0K	1
NAT-LENALIDOMIDE 10MG CAPSULES 28'S (OTH	$50.0K	1
LENALIDOMIDE CAPSULES 20MG 21'S (5490X21	$50.0K	1
LENALIDOMIDE 10MG CAPSULES(APPENDIX 4R,RODTEP ENTRY NO:10112)(OUR REFERENCE CINO:124058)	$50.0K	1
LENALIDOMIDE 25MG CAPSULES(APPENDIX 4R,RODTEP ENTRY NO:10112)(OUR REFERENCE CINO:124058)	$50.0K	1
LENALIDOMIDE CAPSULES 2.5MG 28'S (3889X2	$34.9K	1
LENALIDOMIDE 10MG CAPSULES 28'S (LENALID 10 )(887X28'S)(APPENDIX 4R,RODTEP ENTRY NO:10112)(OUR REF(S)CI NO:124070)	$21.9K	1
LENALIDOMIDE 25MG CAPSULES 21'S (LENALID 25 )(520X21'S)(APPENDIX 4R,RODTEP ENTRY NO:10112)(OUR REF(S)CI NO:124070)	$14.6K	1
LENALIDOMIDE 5MG CAPSULES 28'S (LENALID 5 )(402X28'S)(APPENDIX 4R,RODTEP ENTRYNO:10112)(OUR REF(S)CI NO:124070)	$6.8K	1

Natco Pharma Limited exports 25 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LENALIDOMIDE CAPSULES 20 MG 21'S (4991X21'S)(APPENDIX 4RRODT with 3 shipments worth $150.0K.

How Does Natco Pharma Limited Compare to Nearest Lenalidomide Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	CIPLA LIMITED	$2.1M	42	6	$50.0K
6	HETERO LABS LIMITED	$1.1M	23	8	$50.0K
7	NATCO PHARMA LIMITED ★	$1.1M	31	6	$35.6K
3	DR REDDYS LABORATORIES LIMITED	$200.0K	4	3	$50.0K
8	DR REDDY S LABORATORIES LIMITED	$150.0K	3	2	$50.0K

Natco Pharma Limited ranks #7 among 237 Indian Lenalidomide exporters. Average shipment value of $35.6K compared to the market average of $128.1K. The closest competitors by value are CIPLA LIMITED and HETERO LABS LIMITED.

Which Indian Ports Ship Lenalidomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	740	27.2%
SAHAR AIR	688	25.3%
DELHI AIR CARGO ACC (INDEL4)	187	6.9%
Bombay Air	180	6.6%
DELHI AIR	140	5.1%
Bombay Air Cargo	88	3.2%
HYDERABAD ACC (INHYD4)	78	2.9%
HYDERABAD AIR	68	2.5%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Lenalidomide Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 31 individual customs records matching Natco Pharma Limited exporting Lenalidomide, covering 25 formulations to 6 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 557+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lenalidomide

Lenalidomide

Natco Pharma Limited — Lenalidomide Exporter Profile

Natco Pharma Limited — Lenalidomide Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Lenalidomide?

Who Are the Top Buyers of Lenalidomide from Natco Pharma Limited?

What Is India's Total Lenalidomide Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Lenalidomide Exports?

How Does Natco Pharma Limited Compare to Other Indian Lenalidomide Exporters?

What Lenalidomide Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Lenalidomide to Key Markets

United States — FDA

Canada — HC

How Does Natco Pharma Limited Compare to Nearest Lenalidomide Exporters?

Which Indian Ports Ship Lenalidomide Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Lenalidomide Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lenalidomide Export Data from Natco Pharma Limited

Lenalidomide Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source